BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21378089)

  • 1. Bone loss after childhood acute lymphoblastic leukaemia: an observational study with and without GH therapy.
    Follin C; Link K; Wiebe T; Moëll C; Björk J; Erfurth EM
    Eur J Endocrinol; 2011 May; 164(5):695-703. PubMed ID: 21378089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
    van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
    Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
    Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia.
    Jarfelt M; Fors H; Lannering B; Bjarnason R
    Eur J Endocrinol; 2006 Feb; 154(2):303-9. PubMed ID: 16452545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency.
    Conway GS; Szarras-Czapnik M; Racz K; Keller A; Chanson P; Tauber M; Zacharin M;
    Eur J Endocrinol; 2009 Jun; 160(6):899-907. PubMed ID: 19324976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B; Kann PH
    Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
    Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
    Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
    Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency.
    Elbornsson M; Götherström G; Bosæus I; Bengtsson BÅ; Johannsson G; Svensson J
    Eur J Endocrinol; 2012 May; 166(5):787-95. PubMed ID: 22318746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
    Follin C; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly.
    Murray RD; Columb B; Adams JE; Shalet SM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1124-30. PubMed ID: 15001597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma.
    Holmer H; Popovic V; Ekman B; Follin C; Siversson AB; Erfurth EM
    Eur J Endocrinol; 2011 Jul; 165(1):25-31. PubMed ID: 21502326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
    Thomas IH; Donohue JE; Ness KK; Dengel DR; Baker KS; Gurney JG
    Cancer; 2008 Dec; 113(11):3248-56. PubMed ID: 18932250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.